Adherence to antiretroviral (ARV) therapy remains a major challenge in HIV therapeutics.
Objective:
To assess the adherence to ARV therapy by measuring the delay in monthly refilling of ARV drugs using pharmacy records and to correlate this with HIV plasma RNA measurements and CD4+ cell count.
Method:
Records of 170 HIV-positive patients were examined to identify HIV viral load (VL)/CD4+ results and the time interval to refill ARVs at the pharmacy. The correlation between the number of days missed to refill ARVs and plasma HIV-RNA detectability/CD4+ count was performed using the Spearman’s correlation coefficient (r).
Results:
Fewer days missed to refill ARV was positively correlated with undetectable VL and increase in CD4+ count (r = 0.407 and 0.237, respectively). Increase in adherence was correlated with longer retention in the cohort (r = 0.208).
Conclusion:
Monitoring the delay to pick up ARVs from the pharmacy can be an important and simple tool to identify patients requiring assessment of their adherence.
SimoniJMChenWTHuhD, et al.A preliminary randomized controlled trial of a nurse-delivered medication adherence intervention among HIV-positive outpatients initiating antiretroviral therapy in Beijing, China. AIDS Behav.2011;15(5):919–929.
2.
EnriquezMMcKinseyDS. Strategies to improve HIV treatment adherence in developed countries: clinical management at the individual level. HIV AIDS (Auckl). 2011;3:45–51.
3.
HarwellJIFlaniganTPMittyJA, et al.Directly observed antiretroviral therapy to reduce genital tract and plasma HIV-1 RNA in women with poor adherence. AIDS. 2003;17(13):1990–1993.
4.
MacalinoGEHoganJWMittyJA, et al.A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users. AIDS. 2007;21(11):1473–1477.
5.
McMahonJHJordanMRKelleyK, et al.Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring. Clin Infect Dis. 2011;52(4):493–506.
6.
MillsEJNachegaJBBuchanI, et al.Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296(6):679–690.
7.
VenkateshKKSrikrishnanAKMayerKH, et al.Predictors of nonadherence to highly active antiretroviral therapy among HIV-infected South Indians in clinical care: implications for developing adherence interventions in resource-limited settings. AIDS Patient Care STDS. 2010;24(12):795–803.
8.
WalenskyRPCiaranelloALParkJEFreedbergKA. Cost-effectiveness of laboratory monitoring in sub-Saharan Africa: a review of the current literature. Clin Infect Dis. 2010;51(1):85–92.
9.
GutierrezEBSartoriAMSchmidtAL, et al.Measuring adherence to antiretroviral treatment: the role of pharmacy records of drug withdrawals. AIDS Behav. 2012;16(6):1482–1490.
10.
GardnerEMMelendezAGAstizMBrayK. Adherence and preexisting major protease inhibitor resistance mutations are associated with virologic failure of a dual-class antiretroviral regimen with inhibitors of HIV-1 viral protease and integrase. J Int Assoc Physicians AIDS Care (Chic). 2012;11(1):34–39.
11.
SaberiPCaswellNAmodio-GrotonMAlpertP. Pharmacy-refill measure of adherence to efavirenz can predict maintenance of HIV viral suppression. AIDS Care. 2008;20(6):741–745.
12.
BissonGPGrossRBellamyS, et al.Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy. Plos Med. 2008;5(5):e109.
13.
BissonGPRowhAWeinsteinRGaolatheTFrankIGrossR. Antiretroviral failure despite high levels of adherence: discordant adherence-response relationship in Botswana. J Acquir Immune Defic Syndr. 2008;49(1):107–110.
14.
TownsendMLJacksonGLSmithRWilsonKH. Association between pharmacy medication refill-based adherence rates and CD4 count and viral-load responses: a retrospective analysis in treatment-experienced adults with HIV. Clin Ther. 2007;29(4):711–716.
15.
LittleSJHolteSRoutyJP, et al.Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med. 2002;347(6):385–394.
16.
Lima-DellamoraEDCOsorio-de-CastroCGSMadrugaLGDSLAzeredoTB. Use of pharmacy records to measure treatment adherence: a critical review of the literature. Cad Saude Publica. 2017;33(3):e00136216.
17.
MartinDLuzPMLakeJE, et al.Pharmacy refill data can be used to predict virologic failure for patients on antiretroviral therapy in Brazil. J Int AIDS Soc. 2017;20(1):21405.
18.
ShubberZMillsEJNachegaJB, et al.Patient-reported barriers to adherence to antiretroviral therapy: a systematic review and meta-analysis. Plos Med. 2016;13(11):e1002183.
19.
GilbertEMGerzenshteinL. Integration of outpatient infectious diseases clinic pharmacy services and specialty pharmacy services for patients with HIV infection. Am J Health Syst Pharm. 2016;73(11):757–763.
20.
DesaiKRChewningBWilcoxASafdarN. Mail-order pharmacy experience of veterans living with AIDS/HIV. Res Social Adm Pharm. 2018;14(2):153–161.
21.
ChengYNickmanNAJamjianC, et al.Predicting poor adherence to antiretroviral therapy among treatment-naive veterans infected with human immunodeficiency virus. Medicine (Baltimore). 2018;97(2): e9495.
22.
DewingSMathewsCLurieMKageeAPadayacheeTLombardC. Predictors of poor adherence among people on antiretroviral treatment in Cape Town, South Africa: a case-control study. AIDS Care. 2015;27(3):342–349.
23.
RochaGMMachadoCJAcurcio FdeAGuimarãesMD. Monitoring adherence to antiretroviral treatment in Brazil: an urgent challenge. Cad Saude Publica. 2011;27(suppl 1):S67–S78.
24.
de BoerIMPrinsJMSprangersMANieuwkerk PT. Using different calculations of pharmacy refill adherence to predict virological failure among HIV-infected patients. J Acquir Immune Defic Syndr. 2010;55(5):635–640.
25.
GrimesDEAndradeRANiemeyerCRGrimesRM. Measurement issues in using pharmacy records to calculate adherence to antiretroviral drugs. HIV Clin Trials. 2013;14(2):68–74.
26.
SheaterSJJonesMC. Reliable data-based bandwidth selection method for kernel density estimation. J R Statist Soc B. 1991;53(3):683–690.
27.
GrossbergRZhangYGrossR. A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV. J Clin Epidemiol. 2004;57(10):1107–1110.
28.
NachegaJBHislopMDowdyDW, et al.Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. J Acquir Immune Defic Syndr. 2006;43(1):78–84.
29.
NdubukaNOEhlersVJ. Adult patients’ adherence to anti-retroviral treatment: a survey correlating pharmacy refill records and pill counts with immunological and virological indices. Int J Nurs Stud. 2011;48(11):1323–1329.
30.
GardnerEMBurmanWJMaraviMEDavidsonAJ. Durability of adherence to antiretroviral therapy on initial and subsequent regimens. AIDS Patient Care STDS. 2006;20(9):628–636.
31.
GarciaRBadaroRNettoEM, et al.Cross-sectional study to evaluate factors associated with adherence to antiretroviral therapy by Brazilian HIV-infected patients. AIDS Res Hum Retroviruses. 2006;22(12):1248–1252.
32.
AdeniyiOVAjayiAITer GoonDOwolabiEOEbohALambertJ. Factors affecting adherence to antiretroviral therapy among pregnant women in the Eastern Cape, South Africa. BMC Infect Dis. 2018;18(1):175.
33.
KimJLeeEParkBJBangJHLeeJY. Adherence to antiretroviral therapy and factors affecting low medication adherence among incident HIV-infected individuals during 2009-2016: a nationwide study. Sci Rep. 2018;8(1):3133.
34.
WastiSPSimkhadaPRandallJFreemanJVvan TeijlingenE. Factors influencing adherence to antiretroviral treatment in Nepal: a mixed-methods study. Plos One. 2012;7(5):e35547.
